Home / All Categories / Life Sciences / Medical Devices / Global Intracranial Stents Market Analysis 2018-2029, by Manufacturers, Regions, Countries, Types, Applications and Forecast
Global Intracranial Stents Market Analysis 2018-2029, by Manufacturers, Regions, Countries, Types, Applications and Forecast
Global Intracranial Stents Market Analysis 2018-2029, by Manufacturers, Regions, Countries, Types, Applications and Forecast

Pages: 141       Published Date: Jul 18 2023       Category: Medical Devices       Report ID: HJR418555
The Intracranial Stents industry is a crucial sector within the medical devices market, primarily dedicated to the treatment of ischemic stroke and hemorrhagic stroke. Intracranial stents are medical devices designed to be implanted within the blood vessels of the brain to provide support and prevent further damage in these critical conditions.

According to the comprehensive report released by HJResearch, it is expected that the global market size for Intracranial Stents in 2022 will reach an impressive figure of US$334.1 million, experiencing a robust compound annual growth rate of 14.41%. This forecast emphasizes the increasing demand for these devices and its promising future prospects.

Ischemic stroke, caused by a blockage or clot within a blood vessel supplying the brain, and hemorrhagic stroke, resulting from bleeding within the brain, are severe medical conditions that require urgent medical intervention. Intracranial stents play a crucial role in the treatment of these conditions by providing support and restoring proper blood flow to the affected areas.

The global Intracranial Stents market is currently dominated by key players in the industry, including Medtronic, Stryker, MicroVention (Terumo), Abbott, Balt, Boston Scientific, Obex Medical, Depuy Synthes (Johnson & Johnson), and MicroPort Scientific. These manufacturers have established their position in the market by offering a range of innovative and effective products that cater to the specific needs of patients and healthcare professionals.

The increasing prevalence of stroke worldwide, coupled with the advancements in technology and medical procedures, has significantly contributed to the growth of the Intracranial Stents industry. Additionally, the rising awareness about stroke as a leading cause of mortality and morbidity has prompted healthcare systems to invest in modern treatment options, further driving the demand for these devices.

Furthermore, the rapid development of emerging economies and the subsequent improvement in healthcare infrastructure have created new avenues for market growth. Initiatives by governments and healthcare organizations to raise awareness about stroke, implement early intervention programs, and improve access to quality healthcare are expected to propel the market forward.

In conclusion, the Intracranial Stents industry is witnessing substantial growth and is projected to continue expanding at an impressive rate. With the increasing prevalence of stroke and the growing emphasis on stroke management and treatment, the demand for these innovative medical devices is set to rise. The presence of major manufacturers and their commitment to technological advancements further contribute to the positive industry outlook. As a result, the global Intracranial Stents market is positioned for a promising future and represents a lucrative opportunity for both established players and new entrants in the market.

The SWOT analysis of the Intracranial Stents industry is as follows:

Strengths:
1. Increasing prevalence of cerebrovascular diseases and neurological disorders offers a significant market potential for intracranial stents.
2. Technological advancements in intracranial stent products, such as better designs and materials, leading to improved outcomes and patient satisfaction.
3. Growing adoption of minimally invasive procedures in neurosurgery, driving the demand for intracranial stents.
4. Increasing support from regulatory bodies for the development and commercialization of intracranial stents.
5. Strong research and development activities by key players to introduce innovative products in the market.

Weaknesses:
1. High costs associated with intracranial stents may limit their adoption, particularly in emerging economies with limited healthcare budgets.
2. Limited availability of skilled professionals who can perform intracranial stent procedures.
3. The risk of complications associated with intracranial stenting, such as device migration or restenosis, can impact patient outcomes and overall market perception.

Opportunities:
1. Rising geriatric population, as they are more prone to cerebrovascular diseases, creates a significant opportunity for the intracranial stents industry.
2. Increasing healthcare expenditure and improving healthcare infrastructure in emerging economies can drive market growth.
3. Potential for market expansion through the development of new applications of intracranial stents, such as in the treatment of aneurysms or other neurovascular disorders.
4. Collaborations between key industry players and healthcare providers to improve awareness and accessibility of intracranial stents.
5. Growing demand for minimally invasive procedures in neurosurgery opens new avenues for the adoption of intracranial stents.

Threats:
1. Stringent regulatory requirements and approval processes may hinder market growth and delay product commercialization.
2. Potential risks associated with intracranial stenting procedures, such as blood clots or in-stent thrombosis, may lead to safety concerns among physicians and patients.
3. Competition from alternative treatment modalities, such as medication or traditional surgical procedures, may impact the adoption rate of intracranial stents.
4. Economic volatility and financial constraints in healthcare systems globally can limit the funding for intracranial stent procedures.
5. The potential risk of complications or adverse events associated with intracranial stents may lead to legal and liability issues for manufacturers.

Key players in global Intracranial Stents market include:
Medtronic
Stryker
MicroVention(Terumo)
Abbott
Balt
Boston Scientific
Obex Medical
Depuysynthes(Johnson & Johnson)
MicroPort Scientific

Market segmentation, by product types:
Self-expandable Stents
Balloon-expanded Stents

Market segmentation, by applications:
Ischemic Stroke
Hemorrhagic Stroke

Purchase this Market Research Report

Single User License $3,200.00
Multi User License $5,800.00
Enterprise User License $5,800.00
Add to Cart Buy Now
goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico goods_purchanse_ico